Sinopharm
1099.HK
#1960
Rank
HK$64.12 B
Marketcap
HK$20.55
Share price
-3.52%
Change (1 day)
5.07%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Sinopharm (1099.HK) - Cash on Hand

Cash on Hand as of December 2023 : HK$70.25 Billion

According to Sinopharm's latest financial reports the company has HK$70.25 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Sinopharm - Cash on Hand chart (from 2008 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31HK$76.19 B43.01%
2021-12-31HK$53.28 B-10.73%
2020-12-31HK$59.68 B36.6%
2019-12-31HK$43.69 B-4.88%
2018-12-31HK$45.93 B17.99%
2017-12-31HK$38.93 B36.29%
2016-12-31HK$28.56 B19.62%
2015-12-31HK$23.87 B25.14%
2014-12-31HK$19.08 B6.35%
2013-12-31HK$17.94 B47.22%
2012-12-31HK$12.18 B-24.67%
2011-12-31HK$16.17 B83.89%
2010-12-31HK$8.79 B2.41%
2009-12-31HK$8.59 B279.13%
2008-12-31HK$2.26 B8.4%
2007-12-31HK$2.09 B14.1%
2006-12-31HK$1.83 B